Coronavirus Update: Moderna Prepares For Crucial Phase II Trial Of Vaccine, Japan Takes Steps
At Risk Age Groups Added To Phase I Studies
• By Scrip Team
Plus: Japan pledges rapid approval for remdesivir, GSK launches fund to look into impact of coronavirus on people with HIV.